Global Heart Defects Closure Device Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global Heart Defects Closure Device market size was valued at US$ 378 million in 2024 and is forecast to a readjusted size of USD 465 million by 2031 with a CAGR of 3.0% during review period.

Heart defect closure devices are permanent implants designed to close defects between chambers of the heart or a patent ductus arteriosus. These are self-expandable, self-centering umbrella-like devices. The design and shape of the devices vary, as does their exact mode of deployment. They are implanted in the defect in a cardiac catheterization laboratory, through catheters inserted into either a vein or an artery (transcatheter or percutaneous approach). There are several types of defects, which include atrial septal defect (ASD), persistent patent ductus arteriosus (PDA), ventricular septal defect (VSD), patent foramen ovale (PFO), and left atrial appendage (LAA). Most of these defects are congenital, but can occur after a myocardial infarction or can be the result of a surgical repair of other congenital heart defects.

Global Heart Defect Closure Devices key players include St. Jude Medical, Starway, LifeTech, etc. Global top three manufacturers hold a share about 85%.

United States is the largest market, with a share about 70%, followed by Europe and China, both have a share over 25 percent.

In terms of product, ASD Closure Devices is the largest segment, with a share about 41%.

This report is a detailed and comprehensive analysis for global Heart Defects Closure Device market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Heart Defects Closure Device market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Heart Defects Closure Device market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Heart Defects Closure Device market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Heart Defects Closure Device market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Heart Defects Closure Device

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Heart Defects Closure Device market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, W.L. Gore, Medtronic Plc., Boston Scientific Corporation, St. Jude Medical, Inc., Biosense Webster, Inc., Lifetech Scientific, Starway Medical Technology, Inc., Cardia, Inc., Occlutech Holding AG, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Heart Defects Closure Device market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Atrial Septal Defect ( ASD ) Closure Device
Left Atrial Appendage ( LAA ) Closure Device
Patent Foramen Ovale ( PFO ) Closure Device
Patent Ductus Arteriosus ( PDA ) Closure Device
Ventricular Septal Defect ( VSD ) Closure Device
Others

Market segment by Application
Hospitals
Clinics

Major players covered
Abbott
W.L. Gore
Medtronic Plc.
Boston Scientific Corporation
St. Jude Medical, Inc.
Biosense Webster, Inc.
Lifetech Scientific
Starway Medical Technology, Inc.
Cardia, Inc.
Occlutech Holding AG
SentreHEART, Inc.

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Heart Defects Closure Device product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Heart Defects Closure Device, with price, sales quantity, revenue, and global market share of Heart Defects Closure Device from 2020 to 2025.

Chapter 3, the Heart Defects Closure Device competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Heart Defects Closure Device breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Heart Defects Closure Device market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Heart Defects Closure Device.

Chapter 14 and 15, to describe Heart Defects Closure Device sales channel, distributors, customers, research findings and conclusion.